Comparison of snakebite cases in children and adults

dc.contributor.authorTekin, R.
dc.contributor.authorSula, B.
dc.contributor.authorCakir, G.
dc.contributor.authorAktar, F.
dc.contributor.authorDeveci, O.
dc.contributor.authorYolbas, I.
dc.contributor.authorCelen, M. K.
dc.date.accessioned2024-04-24T17:33:23Z
dc.date.available2024-04-24T17:33:23Z
dc.date.issued2015
dc.departmentDicle Üniversitesien_US
dc.description.abstractOBJECTIVE: There are very few studies that compare the snakebite cases in children and adults. The present study aimed to compare the demographic characteristics, clinical presentations, laboratory findings, and developed complications in pediatric and adult patients due to snakebites. PATIENTS AND METHODS: This study included the patients admitted to the hospital and monitored due to snakebite between July 1999 and December 2012. The condition of each patient who had been bitten was admitted to the hospital was monitored from the time of admission to the end of their hospital stay. The fact that a snakebite occurred was recorded if the subjects saw the snake or if the appearance of the puncture sites was convincingly a snakebite. RESULTS: The present work included 290 patients, of whom 123 were children and 167 were adults. The most common location of the bites was the lower extremity with 78.9% (n=97) and 63.5% (n=106) in pediatric and adult patients, respectively. All of the pediatric patients received prophylactic treatment with antibiotics, whereas 62 (37.1%) adult patients received antimicrobial treatments due to the soft tissue infection. The most common complication developed was pulmonary edema in children at a rate of 33.3% (n=41) and compartment syndrome in adult patients at a rate of 3% (n=5). CONCLUSIONS: Patients admitted to the hospital due to snakebite should be monitored for at least 12 hours, even if there is no sign of clinical envenomation. Antivenom treatment should be administered to the patients requiring clinical staging. Patients should be kept under close monitoring to prevent the development of serious complications such as cellulitis, pulmonary edema, compartment syndrome, and disseminated intravascular coagulation.en_US
dc.identifier.endpage2716en_US
dc.identifier.issn1128-3602
dc.identifier.issue14en_US
dc.identifier.pmid26221904
dc.identifier.scopus2-s2.0-84942303838
dc.identifier.scopusqualityQ2
dc.identifier.startpage2711en_US
dc.identifier.urihttps://hdl.handle.net/11468/20657
dc.identifier.volume19en_US
dc.identifier.wosWOS:000358790400029
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherVerduci Publisheren_US
dc.relation.ispartofEuropean Review For Medical and Pharmacological Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSnakebiteen_US
dc.subjectAntivenomen_US
dc.subjectClinical Featuresen_US
dc.subjectCompartment Syndromeen_US
dc.titleComparison of snakebite cases in children and adultsen_US
dc.titleComparison of snakebite cases in children and adults
dc.typeArticleen_US

Dosyalar